ADMA BIOLOGICS, INC. company info

CIK 1368514
IRS Number 562590442
State of incorporation DE
Business address C/O ADMA BIOLOGICS, INC.
465 STATE ROUTE 17
RAMSEY
NJ
07446
Mail address C/O ADMA BIOLOGICS, INC.
465 STATE ROUTE 17
RAMSEY
NJ
07446

Short summary

ADMA BIOLOGICS, INC. is a New Jersey company, with head office located at C/O Adma Biologics, Inc. Ramsey, New Jersey 07446. In 2019 the company owned a total of 137.78 million USD worth of assets, including 97.32 million USD worth of current assets. 2018 was the year when the company amassed the most assets.

ADMA BIOLOGICS, INC. Income Statement

Name [in Millions USD]20062007200820092010201120122013201420152016201720182019Trends
Revenue, Net 1.123.025.847.0510.5215.62
Gross Profit 00.550.451.042.172.874.30-6.40-25.21
Research and development 2.190.653.479.309.527.027.695.573.93
Operating Expenses 5.505.389.0318.1121.9322.6927.9962.0777.27
Operating Income (Loss) -5.50-4.62-7.91-15.04-16.02-15.51-17.33-39.31-60.29
Interest expense 0.711.600.030.621.291.842.243.295.52
Other Nonoperating Income (Expense) 0.00-0.01-0.13
Income Tax Expense (Benefit) -0.620-0.550000
Net income -0.03-0.02-0.02-0.02-0.03-5.90-7.30-15.53-16.81-17.97-19.52-43.76-65.74

ADMA BIOLOGICS, INC. Balance Sheet

Name [in Millions USD]20062007200820092010201120122013201420152016201720182019Trends
Cash and cash equivalents 0.010.0112.897.6517.877.8212.5525.5755.1573.6248.01
Accounts Receivable, Net, Current 00.220.240.800.520.832.293.805.097.32
Inventories 3.391.200.921.112.454.2113.1512.2523.5940.29
Property, Plant and Equipment, Gross 1.551.551.601.804.124.1528.9932.6734.1235.98
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment -0.47-0.69-0.83-1.041.281.750.36-2.344.675.27
Goodwill 3.533.533.533.53
Intangible Assets, Net (Excluding Goodwill) 6.014.433.583.37
Total assets 0.0115.8810.6927.8829.8031.7484.64117.75143.27137.78
Current assets 3.6814.629.1726.4927.1329.4944.2773.63103.8997.32
Non-current assets 0.440.440.670.350.050.030.03
Accounts payable 0.840.791.162.341.653.324.673.106.798.96
Total current liabilities 0.011.012.033.803.205.0815.656.9210.1315.15
Long-term Debt 0.101.792.7600
Deferred Revenue, Noncurrent 01.541.472.762.622.482.332.30
Total liabilities 9.131.238.9615.5820.2827.8356.9665.9996.37101.66
Common Stock, Value, Issued 0.000.000.000.000.000.000.000.000.010.01
Retained Earnings (Accumulated Deficit) -23.90-31.61-45.25-62.50-77.73-98.04-122.51-183.26-242.72-254.16

ADMA BIOLOGICS, INC. Cash Flow

Name [in Millions USD]20062007200820092010201120122013201420152016201720182019Trends
Net income -0.03-0.02-0.02-0.02-0.03-5.90-7.30-15.53-16.81-17.97-19.52-43.76-65.74
Depreciation and amortization 0.220.220.180.210.250.470.472.693.45
Amortization of Intangible Assets 01.230.84
Depreciation and amortization 0.210.250.470.401.502.60
Accounts receivable 00-0.040.040.380.540.092.86-2.49
Inventories 0.23-0.310.120.400.041.741.57-0.595.99
Accounts payable 0.550.04-0.241.61-0.940.200.482.81-0.02
Deferred revenue 01.7001.530
Net Cash Provided by (Used in) Operating Activities -4.81-1.43-6.90-10.89-14.70-15.42-18.27-37.27-62.68
Payments to Acquire Property, Plant, and Equipment -0.000.000.120.202.320.030.072.682.10
Net Cash Provided by (Used in) Investing Activities -0.00-0.00-0.12-3.13-4.04-1.740.9015.21-2.10
Proceeds from Issuance of Long-term Debt 4300
Proceeds from Issuance of Common Stock 0017.2927.03010.2612.9039.2042.94
Payments for Repurchase of Common Stock 00.15
Net Cash Provided by (Used in) Financing Activities 2.291.2919.4727.639.8010.4016.8460.7542.92
Cash and Cash Equivalents, Period Increase (Decrease) -2.53-0.1412.4513.61-8.95-6.76-0.5338.69-21.85